Screening Program for Critical Cyanotic Congenital Heart Disease for Newborns
Checkout our iOS App for a better way to browser and research.
On or before January 1, 2013, the genetic advisory committee is directed to develop a screening program for critical cyanotic congenital heart disease for the panel of screens authorized for newborns under §68-5-504 that makes use of pulse oximetry.